;

SARC Clinical Studies Now Recruiting

Spotlight

MIB Agents is now accepting Letters of Intent for the 2026 OutSmarting Osteosarcoma grants, with a submission deadline of October 24, 2025. Since 2017, this Family Fund–powered program has awarded $2.5 million to 32 investigators advancing research and hope for osteosarcoma patients.

Get Details »

  • Wednesday
  • Nov 12
  • 2025


PATIENT RESOURCES

yellow ribbon

We understand that finding experienced sarcoma care without delay is the one of the biggest challenges for sarcoma patients and their families.  

COLLABORATING TO CURE SARCOMA

Founded in 2003 as a non-profit sarcoma cancer research organization, we lead domestic and international collaborative discovery, translational research, and clinical trials.

RESOURCES FOR RESEARCHERS

SARC is one of the few organizations focusing on all types of sarcoma. We have the unique ability to promote collaboration and unity among the leading sarcoma researchers.

PARTNER WITH SARC

animated gif of supporter logos

We collaborate with the scientific research community and partner with pharmaceutical and biotech companies bringing SARC’s unique insights, experience, and network to the table.

Back to top